URYPAB traded at 0.0248727 this Tuesday November 3rd, increasing 0.0000001 or 0.001 percent since the previous trading session. Looking back, over the last four weeks, URYPAB gained 0.23 percent. Over the last 12 months, its price fell by 0.97 percent. Looking ahead, we forecast URYPAB to be priced at 0.0249432 by the end of this quarter and at 0.0252781 in one year, according to Trading Economics global macro models projections and analysts expectations.